ArXiv 2608.17128 v1 defines cooperative observation feedback loop for personal AI model quality
The cooperative observation framework recasts personal AI data acquisition as an endogenous feedback loop driven by demonstrated usefulness. Applied to medicine, the loop determines which physiological streams remain accessible to treatment-planning agents. Six-month prototype data and prior EHR retention studies indicate that inspectable outputs are the measurable variable controlling channel persistence.
The paper frames observation as a bounded cooperative process rather than raw data volume. In personalized medicine this implies that wearable, EHR, and self-report streams are filtered by the same usefulness-trust-access cycle. A model that generates inspectable treatment adherence plans can sustain sensor access; repeated plan failures trigger revocation of glucose or medication logs. The single-subject account supplies no aggregate metrics yet records explicit consent toggles after each planning cycle.
Related work on longitudinal patient modeling shows similar dynamics. Rajkomar et al. 2018 demonstrated that EHR-derived predictions degrade when patients withhold follow-up encounters after low-utility outputs. The Organizm loop supplies the missing mechanism: usefulness is the observable variable that determines future data inflow, not an external privacy parameter.
Operationally this predicts narrower but higher-signal observation windows for chronic-disease agents. Systems that surface constraint violations and goal updates in human-readable form retain access to lab values and symptom diaries; opaque agents lose channels within weeks. Evaluation therefore requires logging consent events alongside prediction accuracy rather than static benchmark scores.
Next steps outlined in the preprint include multi-subject trials that quantify observation-channel half-life under different plan-success thresholds in outpatient cohorts.
Organizm: observation-channel retention exceeds 70% at 90-day mark when plan inspection accuracy >85% in 30-patient outpatient cohort by June 2027
Sources (2)
- [1]Primary Source(https://arxiv.org/abs/2608.17128)
- [2]Supporting Source(https://arxiv.org/abs/1801.07860)